{"id":56414,"date":"2023-05-02T04:03:51","date_gmt":"2023-05-02T02:03:51","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/"},"modified":"2023-05-02T04:03:51","modified_gmt":"2023-05-02T02:03:51","slug":"revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/","title":{"rendered":"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order"},"content":{"rendered":"
\n

\nTHIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES<\/i><\/b><\/p>\n

VANCOUVER, British Columbia–(BUSINESS WIRE)–#education<\/a>–Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE:\u00a04DO) (the \u201cCompany<\/b>\u201d or \u201cRevitalist<\/b>\u201d), announces today that it has closed the first tranche of its previously announced non-brokered private placement offering of units (the \u201cUnits<\/b>\u201d) and, in connection therewith, issued an aggregate of 56,975,000 Units, at a price of $0.02 per Unit, for gross proceeds of $1,139,500.\u00a0 Each Unit is comprised of one common share (each, a \u201cShare<\/b>\u201d) and one share purchase warrant (each, a \u201cWarrant<\/b>\u201d), with each Warrant entitling the holder to acquire one additional common share (each, a \u201cWarrant Share<\/b>\u201d) in the capital of the Company at a price of $0.05 for a period two years from the date of issuance.\u00a0 The Units, Shares, Warrants and Warrants Shares are collectively referred to as the \u201cSecurities<\/b>\u201d.\u00a0 The expiry date of the Warrants may be accelerated in the event that the closing price of the Company\u2019s common shares listed on the Canadian Securities Exchange is at least $0.09 per share for any period, after issuance of the Warrants, of ten (10) consecutive trading days.\u00a0 In such event, the Warrants will be deemed to have expired on the day which is thirty (30) days after the date of such notice. \u00a0<\/p>\n

<\/a><\/p>\n

\nThe Securities are subject to a hold period of four months and one day from the date of issuance.\u00a0 Closing of the Offering is subject to approval of the Canadian Securities Exchange. \u00a0The Company intends to use the net proceeds of the Offering to complete and file its 2022 Annual Filings (as defined below) before the Filing Deadline (as defined below), for operations and for general working capital purposes.<\/p>\n

\nThe Company also announces that it has determined that it will not be able to meet the May 1, 2023 filing deadline (the \u201cFiling Deadline<\/b>\u201d) for its annual audited financial statements for the year-ended December\u00a031, 2022, the management discussion and analysis and the related CEO and CFO certifications related to such financial statements (collectively, the \u201c2022 Annual Filings<\/b>\u201d).\u00a0 Although preparation of the financial statements is progressing, the Company anticipates that there will be delays in finalizing the 2022 Annual Filings, such that the Company will not able to meet the Filing Deadline.\u00a0 In the event that the 2022 Annual Filings are not filed by the Filing Deadline, as is anticipated, the Company\u2019s securities will be subject to a \u201cfailure to file\u201d cease trade order pursuant to National Policy 11-207 \u2013 Failure to File Cease Trade Orders and Revocations in Multiple Jurisdictions<\/i>.<\/p>\n

\nThe Company expects to finalize its financial statements, complete its audit, and file the 2022 Annual Filings, as soon as possible but in any event no later than June 15, 2023, and will issue a news release when the 2022 Annual Filings have been filed.<\/p>\n

\nThe Company also announced that the board of directors have authorized the grant of an aggregate of 11,750,000 restricted share units (\u201cRSUs<\/b>\u201d) to eligible consultants.\u00a0 The RSUs were granted pursuant to the Company\u2019s Share Compensation Plan. \u00a0The RSUs will vest on June 1, 2023.<\/p>\n

\nAbout Revitalist Lifestyle and Wellness Ltd.<\/b><\/p>\n

\nRevitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) is a mental health and wellness company focused on comprehensive care in the ketamine wellness space offering innovative, evidenced based services. With physical locations and virtual offices across 28 states, Revitalist is one of the largest publicly traded psychedelic wellness companies in Northern America.<\/p>\n

\nOn Behalf of the Board<\/p>\n

\n\u201cKathryn Walker\u201d<\/i><\/p>\n

\nChief Executive Officer<\/p>\n

\nTwitter:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 @RevitalistCorp
\n
Facebook:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 @RevitalistLifestyleandWellnessLtd.
\n
Instagram:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 @RevitalistCorp
\n
LinkedIn:\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 @RevitalistLifestyleAndWellnessLtd<\/p>\n

\nForward Looking Statements<\/i><\/b><\/p>\n

\nThis news release contains forward-looking statements and forward-looking information (collectively, \u201cforward-looking statements<\/b>\u201d) within the meaning of applicable Canadian legislation. Forward-looking statements are typically identified by words such as: \u201cbelieves\u201d, \u201cexpects\u201d, \u201canticipates\u201d, \u201cintends\u201d, \u201cestimates\u201d, \u201cplans\u201d, \u201cmay\u201d, \u201cshould\u201d, \u201cwould\u201d, \u201cwill\u201d, \u201cpotential\u201d, \u201cscheduled\u201d or variations of such words and phrases and similar expressions, which, by their nature, refer to future events or results that may, could, would, might or will occur or be taken or achieved. All statements in this news release that are not purely historical are forward-looking statements and include statements regarding beliefs, plans, expectations and orientations regarding the future including, without limitation, the completion of the Offering, regulatory approval for the Offering, the anticipate use of proceeds derived from the Offering, completion of the Company\u2019s audit and the anticipated timing of filing its 2022 Annual Filings. \u00a0Although the Company believes that such statements are reasonable and reflect expectations of future developments and other factors which management believes to be reasonable and relevant, the Company can give no assurance that such expectations will prove to be correct. In making the forward-looking statements in this news release, the Company has applied several material assumptions, including without limitation, regulatory approval for the Offering, that the Company and its auditor will complete the audit within the estimated timeline set out herein. \u00a0Other factors may also adversely affect the future results or performance of the Company, including general economic, market or business conditions, changes in laws, regulations and policies affecting the psychedelic wellness industry, as well as the risks and uncertainties which are more fully described in the Company’s annual and quarterly management’s discussion and analysis and in other filings made by the Company with Canadian securities regulatory authorities under the Company’s SEDAR profile. The ongoing COVID-19 pandemic, labour shortages, inflationary pressures, rising interest rates, the global financial climate and the conflict in Ukraine and surrounding regions are some additional factors that are affecting current economic conditions and increasing economic uncertainty, which may impact the Company\u2019s operating performance, financial position, and future prospects. Collectively, the potential impacts of this economic environment pose risks that are currently indescribable and immeasurable. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned that forward- looking statements are not guarantees of future performance or events and, accordingly, are cautioned not to put undue reliance on forward-looking statements due to the inherent uncertainty of such statements. The Company does not undertake any obligation to update such forward\u2010looking information whether because of new information, future events or otherwise, except as expressly required by applicable law.<\/i><\/p>\n

\nThe Canadian Securities Exchange (operated by CNSX Markets Inc.) has neither approved nor
\n
disapproved of the contents of this press release.<\/i><\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information:
\n
Revitalist Lifestyle and Wellness Ltd.
\n
Email: Corporate@Revitalist.com<\/a>
Tel: (865) 585-8414<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE:\u00a04DO) (the \u201cCompany\u201d or \u201cRevitalist\u201d), announces today that it has closed the first tranche of its previously announced non-brokered private placement offering of units (the … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-56414","6":"format-standard","7":"category-industry"},"yoast_head":"\nRevitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE:\u00a04DO) (the \u201cCompany\u201d or \u201cRevitalist\u201d), announces today that it has closed the first tranche of its previously announced non-brokered private placement offering of units (the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-02T02:03:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230501005779\/en\/1780326\/21\/Revitalist_LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order\",\"datePublished\":\"2023-05-02T02:03:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/\"},\"wordCount\":1093,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005779\\\/en\\\/1780326\\\/21\\\/Revitalist_LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/\",\"name\":\"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005779\\\/en\\\/1780326\\\/21\\\/Revitalist_LOGO.jpg\",\"datePublished\":\"2023-05-02T02:03:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005779\\\/en\\\/1780326\\\/21\\\/Revitalist_LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230501005779\\\/en\\\/1780326\\\/21\\\/Revitalist_LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/","og_locale":"en_US","og_type":"article","og_title":"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order - Pharma Trend","og_description":"THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTCQB: RVLWF) (FSE:\u00a04DO) (the \u201cCompany\u201d or \u201cRevitalist\u201d), announces today that it has closed the first tranche of its previously announced non-brokered private placement offering of units (the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/","og_site_name":"Pharma Trend","article_published_time":"2023-05-02T02:03:51+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230501005779\/en\/1780326\/21\/Revitalist_LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order","datePublished":"2023-05-02T02:03:51+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/"},"wordCount":1093,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230501005779\/en\/1780326\/21\/Revitalist_LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/","url":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/","name":"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230501005779\/en\/1780326\/21\/Revitalist_LOGO.jpg","datePublished":"2023-05-02T02:03:51+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230501005779\/en\/1780326\/21\/Revitalist_LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230501005779\/en\/1780326\/21\/Revitalist_LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/revitalist-closes-first-tranche-of-private-placement-offering-grant-of-restricted-share-units-and-announces-anticipated-cease-trade-order\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Revitalist Closes First Tranche of Private Placement Offering, Grant of Restricted Share Units and Announces Anticipated Cease Trade Order"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56414","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=56414"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/56414\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=56414"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=56414"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=56414"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}